Kinaset Therapeutics - About the company
Kinaset Therapeutics is a series B company based in Boston (United States), founded in 2020 by Robert Clarke and Frazer Morgan. It operates as a Developer of therapeutics to treat asthma. Kinaset Therapeutics has raised $172M in funding from investors like Atlas Venture, Gimv and 5AM Ventures. The company has 11 active competitors, including 6 that are funded. Its top competitors include companies like Areteia, Sitryx and DeepCure.
Company Details
Developer of therapeutics to treat asthma. The company's proprietary product includes KN-002 which is an inhibitor of pan-JAK used to treat severe asthma. It is inhaled and delivered to the site of inflammation in the lung and minimizes systemic exposure.
- Website
- www.kinasettherapeutics.com/
- Social
- Email ID
- *****@kinasettx.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2020
Location
Boston, United States
Stage
Series B
Total Funding
$172M in 3 rounds
Latest Funding Round
Investors
Ranked
1st among 11 active competitors
Sign up to download Kinaset Therapeutics' company profile
Kinaset Therapeutics's funding and investors
Kinaset Therapeutics has raised a total funding of $172M over 3 rounds. Its first funding round was on Nov 30, 2020. Its latest funding round was a Series B round on Jan 12, 2026 for $*****. 11 investors participated in its latest round. Kinaset Therapeutics has 11 institutional investors.
Here is the list of recent funding rounds of Kinaset Therapeutics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 12, 2026 | 7989984 | Series B | 9217183 | 1674094 | 6958352 | 2112942 |
Jul 17, 2023 | 4575301 | Series A | 6836656 | 8245096 | 4473485 | 5513185 |
Nov 30, 2020 | 6704104 | Series A | 4937634 | 7231024 | 9471322 |
Access funding benchmarks and valuations. Sign up today!View details of Kinaset Therapeutics's funding rounds and investors
Kinaset Therapeutics' founders and board of directors
Founder? Claim ProfileThe founders of Kinaset Therapeutics are Robert Clarke and Frazer Morgan. Robert Clarke is the CEO of Kinaset Therapeutics.
Here are the details of Kinaset Therapeutics' key team members:
- Robert Clarke: Co-Founder & CEO of Kinaset Therapeutics.
- Frazer Morgan: Co-Founder of Kinaset Therapeutics.
View details of Kinaset Therapeutics's Founder profiles and Board Members
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Kinaset Therapeutics's Competitors and alternates
Top competitors of Kinaset Therapeutics include Areteia, Sitryx and DeepCure. Here is the list of Top 10 competitors of Kinaset Therapeutics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Kinaset Therapeutics 2020, Boston (United States), Series B | Developer of therapeutics to treat asthma | $172M | 55/100 | |
2nd |  Areteia 2022, Durham (United States), Series A | Developer of therapeutics for eosinophilic asthma | $435M | 54/100 | |
3rd | Sitryx 2018, Oxford (United Kingdom), Series B | Biotechnology company focused on immunometabolism, developing therapies | $109M | 53/100 | |
4th | DeepCure 2018, Boston (United States), Series A | Developer of novel small molecule therapies for immune diseases | $64.6M | 49/100 | |
5th |  Auron Therapeutics 2018, Wellesley (United States), Series B | Developer of cancer therapeutics for the treatment of blood cancer | $118M | 48/100 | |
6th |  Atopia Therapeutics 2016, Geneva (Switzerland), Unfunded | Developer of therapeutics for asthma and other allergic diseases | - | - | 39/100 |
7th | Oxagen 1996, Abingdon (United Kingdom), Deadpooled | Developer of drugs for inflammatory and respiratory diseases | $86.5M | 30/100 | |
8th | Pantherics 2017, San Diego (United States), Funding Raised | Developer of therapeutics for respiratory disorders | - | 30/100 | |
9th |  HpVac 2016, Geneva (Switzerland), Unfunded | Developer of therapeutics for immunological disorders | - | - | 26/100 |
10th |  GBC-HpVac 2016, Geneva (Switzerland), Unfunded | Developer of a drug for allergic diseases and asthma | - | - | 26/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Kinaset Therapeutics's competitors? Click here to see the top ones
Kinaset Therapeutics's Investments and acquisitions
Kinaset Therapeutics has made no investments or acquisitions yet.
Reports related to Kinaset Therapeutics
Here is the latest report on Kinaset Therapeutics's sector:
News related to Kinaset Therapeutics
Media has covered Kinaset Therapeutics for a total of 2 events in the last 1 year.
•
EQT Life Sciences Backs Kinaset Therapeutics' USD103 Million Series BPR Newswire•Jan 12, 2026•Forge Life Science Partners, Kinaset Therapeutics, EQT, RA Capital Management and 8 others
•
•
•
•
Kinaset Therapeutics debuts with $40M for pan-JAK asthma medFierce Biotech•Nov 30, 2020•Kinaset Therapeutics, 5AM Ventures, Atlas Venture, Gimv
•
Vectura joins forces with Kinaset Therapeutics to develop and commercialise asthma treatmentProactive•Nov 30, 2020•Vectura, Kinaset Therapeutics, Atlas Venture, 5AM Ventures and 1 other
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Kinaset Therapeutics
Explore our recently published companies
- Juuso Kivialho - Finland based, Unfunded company
- JBL Trucking and Excavating - United States based, 2017 founded, Unfunded company
- Samrat Masala - Jamnagar based, 2001 founded, Unfunded company
- All In One Life Coaching - Edmonton based, Unfunded company
- SearchFindOrder - Milton based, 2020 founded, Unfunded company
- Summitepc - Unfunded company
